Windlas Biotech

Price chart

Previous close

₹1,018.40

Open

₹1,005.00

Day high

₹1,012.35

Day low

₹982.30

Listed on NSE since 16 August 2021.

Market value

₹2,052.07 Cr

P/E (trailing)

31.81

EPS (trailing)

₹31.26

Price to book

3.60

Dividend yield

0.63%

Return on equity

12.1%

Debt to equity

0.09

Profit margin

6.7%

Volume today

30,281

Average volume

1.93 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: Windlas Biotech’s results filed with NSE, standalone (the company alone). Net profit is the share of Windlas Biotech’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: Windlas Biotech’s half-yearly statements of assets and liabilities filed with NSE, standalone. Companies file these every September and March.

Windlas Biotech Limited, a contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India. The company offers contract manufacturing; customized formulations; contract research and manufacturing services; customized formulation; and regulatory services. It also manufactures tablets, capsules, oral solids, modified-release formulations, chewable and dispersible tablets, customized generics, and complex generics and multi-drug combinations, as well as injectables, including liquid vials, lyophilized vials, and ampoules. In addition, the company offers generic drugs for respiratory, anti-diabetic, gastroenterology, cardiovascular and multivitamin, neuro anti-psychotic, diabetic care, nutraceuticals, nutritional supplement, urology, pain management, and injectable therapies. It also exports generic medicines, health supplements, and custom-branded formulations. The company sells generic medicines, health supplements, and custom-branded formulations under Windlas brand names. Windlas Biotech Limited was incorporated in 2001 and is headquartered in Dehradun, India.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Dehradun

Employees

1,385

Company website · Profile: Yahoo Finance

No headlines name Windlas Biotech in the last day or two.

• Dividend - Rs 6.30 Per Share

  Dividend · ex-date 16 July 2026

• Buy Back

  Buyback · ex-date 24 April 2026

• Dividend - Rs 5.80 Per Share

  Dividend · ex-date 21 July 2025

• Annual General Meeting

  Action · ex-date 17 September 2024

• Dividend - Rs 5.50 Per Share

  Dividend · ex-date 17 September 2024

• Annual General Meeting/Dividend - Rs 4 Per Share

  Dividend · ex-date 5 September 2023

• Annual General Meeting/Dividend - Rs 3.50 Per Share

  Dividend · ex-date 9 September 2022

Source: NSE. Latest first.